Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
68.0%
% of BBH's 27 holdings also in FBT
56.7%
% of FBT's 31 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 15.3% | 3.5% | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 9.7% | 3.4% | 3.4% |
|
REGENERON PHARMACEUTICALS | 7.9% | 3.4% | 3.4% |
|
BIOGEN IDEC INC | 4.3% | 3.4% | 3.4% |
|
GILEAD SCIENCES INC | 8.0% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to FBT
|
AMGEN INC | 11.8% |
|
VERTEX PHARMACEUTICALS INC | 6.3% |
|
IQVIA HOLDINGS INC | 4.9% |
|
GILEAD SCIENCES INC | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.5% |
 |
ICON PLC | 4.2% |
|
CHARLES RIVER LABORATORIES | 2.5% |
|
SAREPTA THERAPEUTICS INC | 2.4% |
|
MODERNA, INC. | 2.3% |
|
BIO-TECHNE CORPORATION | 2.1% |
BBH Underweight Relative to FBT
|
INTRA-CELLULAR THERAPIES INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.5% |
|
HALOZYME THERAPEUTICS INC | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -3.4% |
|
EXELIXIS INC | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
ALKERMES PLC | -3.4% |
|
CORCEPT THERAPEUTICS INC | -3.4% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.2% |